Gene Therapy & Viral Vaccines
SAFC and BioReliance offer world-class process development and manufacturing capabilities for virus based therapeutic products (e.g. gene therapy and viral vaccines). From small scale toxicology and Phase I materials to commercial-scale manufacturing and fill-finish, our flexible facilities and dedicated staff can assure that product yields and critical timelines are met.
Quality – All facilities are fully validated and GMP compliant
Process Development – Experienced scientists and highly-trained personnel can successfully develop a robust virus manufacturing process (or transfer a complex process) to produce small-scale clinical to large-scale commercial product using most disposable and stainless-steel based systems
Range of Capabilities – Experience manufacturing most virus based systems. Global, dual-site capacity ensures continuity of supply.
Commercial Scale Manufacturing and Final Fill/Finish – FDA inspected facilities, fill-finish capacity from 2,000 to 10,000 vials per day
Expanded Capability – Combined with BioReliance leading biologics safety testing services, clients can count on an integrated package of manufacturing and safety assessment service to ensure successful product development
Visit the pages below to learn more about the range of SAFC and BioReliance’s services for gene therapy and virus vaccine manufacturing: